Loading
Latest filing published 03 Mar 2026 for Lexicon Pharmaceuticals, INC..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Wendy McDermott in Lexicon Pharmaceuticals, Inc. The record holds 15 filings, for trades running from 28 February 2023 to 28 February 2026.
The open-market record is one-sided, with 2 purchases worth €32k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 9 option exercises.
The latest filing, published on 3 March 2026, reports an option exercise in Lexicon Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,174 days ago, on 7 August 2023. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations